Biotech Essentials

Career and Jobs

Biotech Career and Jobs Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 22.04.2021.

#lifesciences
#pharmaceuticals
#HealthcareNews
#biotechnology
#COVID19
#Vaccine
#moversandshakers
#PharmiwebNews
#PharmaNews
#MedicalNews

Career And Jobs

@MALifeSciences shared
On Apr 16, 2021
RT @MassBioEd: Join us on 6/2 for discussions on the future landscape of the #lifesciences in MA at MassBioEd's 6th Annual Life Sciences Workforce Conference and to analyze the effects of 2020 on the industry with the release of the 2020 Life Sciences Employment Outlook. https://t.co/E3YF6z6fHK https://t.co/vpaOmsnL1o
Open
Life Sciences Workforce Conference

Life Sciences Workforce Conference

The Life Sciences Workforce Conference is uniquely devoted to bringing together the life sciences industry and academia to discuss training of the next generation of leaders.

@NEBiolabs shared
On Apr 20, 2021
Wondering why so few life science companies become a @BCorporation? @Forbes was wondering too.... https://t.co/nEZCku5iWl
Open
Why Are So Few Life Sciences Companies Certified B Corps?

Why Are So Few Life Sciences Companies Certified B Corps?

Many life sciences companies say their primary mission is to contribute to individuals’ health and well-being, yet few are Certified B Corps. Brian Tinger, from recently certified New ...

@Biotechnology shared
On Apr 16, 2021
BioSpace Movers & Shakers, April 16 https://t.co/ge2vPONqTK https://t.co/aDPhdi691F
Open
BioSpace Movers & Shakers, April 16

BioSpace Movers & Shakers, April 16

Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

@biospace shared
On Apr 21, 2021
Let’s get to know Paula Ragan, CEO and president of @X4Pharma #lifesciences #biotechnology #pharmaceuticals https://t.co/39QpoVEKIj
Open
Let’s Get to Know Paula Ragan, CEO and President of X4 Pharmaceuticals

Let’s Get to Know Paula Ragan, CEO and President of X4 Pharmaceuticals

BioSpace spoke with Paula Ragan, CEO and President of X4 Pharmaceuticals, a company focused on restoring healthy immune system function in people with rare diseases.

@Pharmafocus shared
On Apr 22, 2021
Bharat Biotech jab shows 100% efficacy against severe COVID-19 https://t.co/uCJdA0RumC #COVID19 #Vaccine https://t.co/pWpJqRG4wH
Open
Bharat Biotech jab shows 100% efficacy against severe COVID-19

Bharat Biotech jab shows 100% efficacy against severe COVID-19

Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, jobs, events, and service company listings.

@GENbio shared
On Apr 21, 2021
Check out GEN's Top 10 Life Sciences Jobs Most in Demand over the Next Decade by @AlexWestchester. Employment continues to trend higher through 2029, showing resilience against the pandemic: https://t.co/VT1RaoVOPB
Open
Top 10 Life Sciences Jobs Most in Demand over the Next Decade

Top 10 Life Sciences Jobs Most in Demand over the Next Decade

COVID-19 may have wreaked havoc on the U.S. economy last year, but it did not derail biotech employment. If anything, the pandemic is expected to stoke increasing numbers of jobs during ...

@FierceBiotech shared
On Apr 16, 2021
If all goes to plan, the deal will close in the third quarter and the combined company will receive $92 million from the SPAC, as well as $120 million through a private round https://t.co/jzrw4Rg50v
Open
Regenerative medicine biotech Surrozen aims for the Nasdaq in $212M SPAC deal

Regenerative medicine biotech Surrozen aims for the Nasdaq in $212M SPAC deal

After banking two $50 million venture rounds about a year apart, Surrozen is ready to hit Wall Street. The company plans to go public via SPAC in a deal worth up to $212 million. ...

@pharminews shared
On Apr 16, 2021
GSK and Vir Biotechnology announce EMA review of dual-action monoclonal antibody VIR-7831 for the early treatment of COVID-19 https://t.co/RbU72jJUp8 #PharmaNews #ClinicalResearchNews #BiotechNews #LifeSciencesNews #MedicalNews #HealthcareNews #PharmiwebNews https://t.co/e0DQ26AEmw
Open
GSK and Vir Biotechnology announce EMA review of dual-action monoclonal antibody VIR-7831 for the early treatment of COVID-19

GSK and Vir Biotechnology announce EMA review of dual-action monoclonal antibody VIR-7831 for the early treatment of COVID-19

GlaxoSmithKline plc and Vir Biotechnology, Inc. today announced that the European Medicines Agency (EMA) has started a review of VIR-7831 (GSK4182136), an investigational dual-action ...